Amixetrine

Amixetrine
Clinical data

Routes of administration	Oral
ATC code	none
Legal status
Legal status	℞ (Prescription only)
Identifiers
IUPAC name 1-[2-(3-methylbutoxy)-2-phenylethyl]pyrrolidine
CAS Number	24622-72-8^Y
PubChem (CID)	71911
ChemSpider	64922^Y
UNII	7UL287YTPJ^Y
ChEMBL	CHEMBL2104080^N
Chemical and physical data
Formula	C₁₇H₂₇NO
Molar mass	261.40 g/mol
3D model (Jmol)	Interactive image
SMILES O(CCC(C)C)C(c1ccccc1)CN2CCCC2
InChI InChI=1S/C17H27NO/c1-15(2)10-13-19-17(14-18-11-6-7-12-18)16-8-4-3-5-9-16/h3-5,8-9,15,17H,6-7,10-14H2,1-2H3^Y Key:ISRODTBNJUAWEJ-UHFFFAOYSA-N^Y
^NY (what is this?) (verify)

Amixetrine (INN) (brand name Somagest; developmental code name CERM-898) is a drug that was formerly marketed in France but is now no longer sold.^[1]^[2] According to various sources it has been said to be an anti-inflammatory, antidepressant, antispasmodic, anticholinergic, antihistamine, and antiserotonergic, but its definitive indications and pharmacology are unclear.^[1]^[2] The drug was first synthesized in 1969 and was introduced in France in 1972.^[1]^[2]

References

1 2 3 J. Elks (14 November 2014). The Dictionary of Drugs: Chemical Data: Chemical Data, Structures and Bibliographies. Springer. pp. 80–. ISBN 978-1-4757-2085-3.
1 2 3 William Andrew Publishing (22 October 2013). Pharmaceutical Manufacturing Encyclopedia, 3rd Edition. Elsevier. pp. 285–. ISBN 978-0-8155-1856-3.

This article is issued from Wikipedia - version of the 9/27/2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.